SCHEMBL113266

SCHEMBL113266

COc1ncc(-c2ccccc2N2CCN(C(C=O)n3ccc4cccnc43)CC2)cn1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 3/20 0.35
HTR1A P08908 7/20 0.34
HTR7 P34969 7/20 0.34
SCN9A Q15858 1/20 0.34
NPSR1 Q6W5P4 2/20 0.33
GAA P10253 1/20 0.33
MAPK1 P28482 4/20 0.32
ALDH1A1 P00352 2/20 0.32
CYP3A4 P08684 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
HSD17B10 Q99714 1/20 0.32
KCNH2 Q12809 1/20 0.32
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
NPC1 O15118 1/20 0.32
MAPT P10636 1/20 0.32
RAB9A P51151 1/20 0.32
LMNA P02545 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL115569 0.90 HTR1A (0.38) HTR1AHTR7NPSR1GAAKCNH2
SCHEMBL113317 0.88 DHFR (0.35) DHFRHTR1AHTR7MAPK1ALDH1A1
SCHEMBL114800 0.88 DHFR (0.35) DHFRNPSR1GAAMAPK1ALDH1A1
SCHEMBL114932 0.87 DHFR (0.35) DHFRHTR1AHTR7MAPK1ALDH1A1
SCHEMBL114773 0.87 OGA (0.34) DHFRHTR1ACYP3A4KCNH2MEN1
SCHEMBL112867 0.87 DHFR (0.41) DHFRHTR1AHTR7ALDH1A1HSD17B10
SCHEMBL113706 0.86 PTGS2 (0.33) DHFRHTR1AHTR7NPSR1GAA
SCHEMBL116262 0.86 CXCR3 (0.35) DHFRHTR1AHTR7SCN9ANPSR1
SCHEMBL113518 0.85 ALDH1A1 (0.33) DHFRGAAALDH1A1CYP1A2CYP2C9
SCHEMBL115607 0.85 HTR1A (0.37) DHFRHTR1AHTR7NPSR1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424840-A1 CXCR3 RECEPTOR ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-03-07 EP disclosed
WO-2010126811-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-11-04 WO disclosed